Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Weissman

Showing results (71-80 of 293) with videos related to

Pageof 30
Sort By:
Plos One|October 3, 2012
Effect of solar particle event radiation and hindlimb suspension on gastrointestinal tract bacterial translocation and immune activationYu Zhou, Houping Ni, Minghong Li, et al.
Allergy|September 22, 2022
Nucleoside-modified mRNA vaccines yield robust blocking antibody responses against major house dust mite allergensSirikarn Jitthamstaporn, Rueangsit Inthong, Dittaya Audomsun, et al.
Emerging Microbes & Infections|March 13, 2026
Efficacy and immunological correlates of an mRNA-LNP vaccine for protection against an emerging rickettsial pathogenMingqun Lin, Stephen Denton, Nan Duan, et al.
Plos Pathogens|July 28, 2020
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infectionKevin P Egan, Lauren M Hook, Alexis Naughton, et al.
Bioengineering & Translational Medicine|April 22, 2026
Investigating the impact of hypoxia and syncytialization on lipid nanoparticle-mediated mRNA delivery to placental cellsRachel E Young, Tara Vijayakumar, Logan J Reilley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
HIV envelope binding by macrophage-expressed gp340 promotes HIV-1 infectionGeorgetta Cannon, Yanjie Yi, Houping Ni, et al.
The Journal of Antimicrobial Chemotherapy|May 5, 2017
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TBChristopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 13, 2015
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routesNorbert Pardi, Steven Tuyishime, Hiromi Muramatsu, et al.
Plos One|November 3, 2017
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activationChristopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, et al.
Journal of Biomedical Materials Research. Part A|January 25, 2022
Rational design of anti-inflammatory lipid nanoparticles for mRNA deliveryHanwen Zhang, Xuexiang Han, Mohamad-Gabriel Alameh, et al.
Pageof 30

Showing results (71-80 of 293) with videos related to

Sort By:
Pageof 30
Plos One|October 3, 2012
Effect of solar particle event radiation and hindlimb suspension on gastrointestinal tract bacterial translocation and immune activationYu Zhou, Houping Ni, Minghong Li, et al.
Allergy|September 22, 2022
Nucleoside-modified mRNA vaccines yield robust blocking antibody responses against major house dust mite allergensSirikarn Jitthamstaporn, Rueangsit Inthong, Dittaya Audomsun, et al.
Emerging Microbes & Infections|March 13, 2026
Efficacy and immunological correlates of an mRNA-LNP vaccine for protection against an emerging rickettsial pathogenMingqun Lin, Stephen Denton, Nan Duan, et al.
Plos Pathogens|July 28, 2020
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infectionKevin P Egan, Lauren M Hook, Alexis Naughton, et al.
Bioengineering & Translational Medicine|April 22, 2026
Investigating the impact of hypoxia and syncytialization on lipid nanoparticle-mediated mRNA delivery to placental cellsRachel E Young, Tara Vijayakumar, Logan J Reilley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
HIV envelope binding by macrophage-expressed gp340 promotes HIV-1 infectionGeorgetta Cannon, Yanjie Yi, Houping Ni, et al.
The Journal of Antimicrobial Chemotherapy|May 5, 2017
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TBChristopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 13, 2015
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routesNorbert Pardi, Steven Tuyishime, Hiromi Muramatsu, et al.
Plos One|November 3, 2017
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activationChristopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, et al.
Journal of Biomedical Materials Research. Part A|January 25, 2022
Rational design of anti-inflammatory lipid nanoparticles for mRNA deliveryHanwen Zhang, Xuexiang Han, Mohamad-Gabriel Alameh, et al.
Pageof 30